Literature DB >> 1904332

Defective T lymphocyte function in nonthymectomized patients with myasthenia gravis.

R E Ahlberg1, R Pirskanen, A K Lefvert.   

Abstract

In vitro functional properties of peripheral blood mononuclear cells were evaluated in 29 patients with myasthenia gravis and in 11 healthy controls. Spontaneous cell proliferation was higher in patients than in controls. The production of interleukin-2 and interferon-gamma and the proliferative response to different mitogens were reduced in the patients. A positive correlation was found between the production of interleukin-2 and interferon-gamma. These defects in T cell function were the most pronounced in nonthymectomized patients. Patients with severe disease had a higher percentage of cells bearing the interleukin-2 receptor and a higher spontaneous production of tumor necrosis factor alpha in cell culture than in patients with mild disease. There was no difference between patients and controls in the level of soluble interleukin-2 receptor in cell culture supernatants or in sera. The results indicate a partially suppressed T cell function in myasthenia gravis. This defect was less pronounced in patients studied after thymectomy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1904332     DOI: 10.1016/0090-1229(91)90115-q

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  3 in total

1.  Overexpression of select T cell receptor V beta gene families within CD4+ and CD8+ T cell subsets of myasthenia gravis patients: a role for superantigen(s)?

Authors:  D Gigliotti; A K Lefvert; M Jeddi-Tehrani; S Esin; V Hodara; R Pirskanen; H Wigzell; R Andersson
Journal:  Mol Med       Date:  1996-07       Impact factor: 6.354

2.  Nasal tolerance in experimental autoimmune myasthenia gravis (EAMG): induction of protective tolerance in primed animals.

Authors:  F D Shi; X F Bai; H L Li; Y M Huang; P H Van der Meide; H Link
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

3.  Widely varying TNF-alpha levels in patients with myasthenia gravis.

Authors:  Jin Soo Lee; In Soo Joo; Jung Im Seok
Journal:  Neurol Sci       Date:  2009-02-13       Impact factor: 3.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.